Investigadors
-
Begoña Pina Marín
Oftalmologia
-
Carlos Luis Moser Würth
Oftalmologia
-
Carlos Martínez Belló
Oftalmologia
-
Diana Paola Mora Ramirez
Oftalmologia
-
Joan Josep Escobar Barranco
Oftalmologia
-
Josep Badal Lafulla
Oftalmologia
Phd -
Luis Amselem Gómez
Oftalmologia
-
Magela Garat Chifflet
Oftalmologia
-
Manel Fernández Bonet
Oftalmologia
-
Mónica Lecumberri López
Oftalmologia
-
Rafel Alcubierre Bailac
Oftalmologia
-
Sabrina Bojados
Oftalmologia
-
Stephany Carrillo
Oftalmologia
Contacteu amb el grup
Formulari-
Wu L, Zas M, Berrocal MH, Arevalo JF, Figueroa M, Rodriguez F, Serrano M, Graue F, Alezzandrini A, Gallego-Pinazo R, Roca JA, Iglicki M, Dalma-Weishauz J, Kozak I, Collado A, Badal J, Maia M, Salcedo-Villanueva G, Quiroz-Mercado H, Fromow-Guerra J, Lozano-Rechy D, Avila M, Chhablani J. 1375
ANATOMICAL AND FUNCTIONAL OUTCOMES OF SYMPTOMATIC IDIOPATHIC VITREOMACULAR TRACTION: A Natural History Study From the Pan American Collaborative Retina Study Group.
Retina. 2016;36(10):1913-8.
-
Escobar-Barranco JJ, Pina-Marín B, Fernández-Bonet M. 1301
Dexamethasone implants in patients with naïve or refractory diffuse diabetic macular edema.
Ophthalmologica. 2015;233(3-4):176-85
-
Casaroli-Marano R, Gallego-Pinazo R, Fernández-Blanco CT, Figueroa MS, Pina Marín B, Fernández-Baca Vaca G, Piñero-Bustamante A, Donate López J, García-Arumí J, Farrés Martí J. 1210
Age-Related Macular Degeneration: Clinical Findings following Treatment with Antiangiogenic Drugs.
J Ophthalmol. 2014;2014:346360
-
Mansour AM, Arevalo JF, Badal J, Moorthy RS, Shah GK, Zegarra H, Pulido JS, Charbaji A, Amselem L, Lavaque AJ, Casella A, Ahmad B, Paschall JG, Caimi A, Staurenghi G. 1204
Paraproteinemic maculopathy.
Ophthalmology. 2014;121(10):1925-32.
-
Millá E, Mañé B, Duch S, Hernan I, Borràs E, Planas E, Dias Mde S, Carballo M, Gamundi MJ; Spanish Multicenter Glaucoma Group-Estudio Multicéntrico Español de Investigación Genética del Glaucoma, EMEIGG. (Martínez Belló C) 1153
Survey of familial glaucoma shows a high incidence of cytochrome P450, family 1, subfamily B, polypeptide 1 (CYP1B1) mutations in non-cosanguineous forms in a spanish population.
Molecular Vision 2013;19:1707-1722.
Projectes
-
- Any 2020
- Comprehensive Care Center Dos de Maig Hospital
Multicenter Phase Iii Study, Randomized, With Double Masking, Controlled With Active Comparator, To Evaluate The Efficacy And Safety Of Faricimab In Patients With Macular Edema Secondary To Retinal Venous Branch Occlusion.
-
PROMOTOR:
F. Hoffmann-La Roche Ltd.
-
TIPUS E:
RD2015
- Any 2020
- Comprehensive Care Center Dos de Maig Hospital
A phase III, multicenter, prospective, randomized, double-masked, active-comparator-controlled, two-arm study to evaluate the efficacy and safety of intravitreal KSI-301 compared with intravitreal aflibercept in naïve participants with visual impairment due to macular edema secondary to retinal vein occlusion (RVO).
-
PROMOTOR:
Kodiak Sciences Inc.
-
TIPUS E:
RD2015
- Any 2020
- Sant Joan Despí Moisès Broggi Hospital
Effectiveness of the boost application to predict visual quality in cataract surgery.
-
PROMOTOR:
Monica Lecumberri
-
TIPUS E:
PINE TREE
- Any 2020
- Comprehensive Care Center Dos de Maig Hospital
Preliminary randomized, double-masked, 48-week, parallel-group, placebo-controlled demonstrative study to investigate the efficacy and safety of RG7774 in patients with type 1 or type 2 diabetes mellitus with previously untreated diabetic retinopathy.
-
PROMOTOR:
F. Hoffmann-La Roche Ltd
-
TIPUS E:
RD2015
- Any 2020
- Sant Joan Despí Moisès Broggi Hospital
A phase III, multicenter, prospective, randomized, double-masked, active comparator-controlled, two-treatment arm study to evaluate the efficacy and safety of intravitreal KSI-301 compared with intravitreal aflibercept in naïve participants with secondary visual impairment to diabetic macular edema (DMD).
-
PROMOTOR:
Kodiak Sciences Inc.
-
TIPUS E:
RD2015
- Any 2020
- Sant Joan Despí Moisès Broggi Hospital
Design And Validation Of A Questionnaire For The Telematic Triage Of The First Ophthalmology Visits Derived From The Head Doctor In Primary Care Centers.
-
PROMOTOR:
Stephany Carrillo Cristancho
-
TIPUS E:
PINE TREE
- Any 2020
- Comprehensive Care Center Dos de Maig Hospital
Extension, open and multicenter study to evaluate the long-term safety and tolerability of Faricimab in patients with diabetic macular edema.
-
PROMOTOR:
F. Hoffmann-La Roche Ltd
-
TIPUS E:
RD2015
- Any 2020
- Comprehensive Care Center Dos de Maig Hospital
Phase IIIb/IV, open-label, single-group, 56-week extension study to evaluate the efficacy and safety of brolucizumab 6 mg in a treatment-to-control regimen with maximum treatment intervals of 20 weeks in patients with age-associated neovascular macular degeneration who have completed the CRTH258A2303 (TALON) study.
-
PROMOTOR:
Novartis pharmaceutical, SA
-
TIPUS E:
RD2015
- Any 2020
- Comprehensive Care Center Dos de Maig Hospital
Retrospective observational study to evaluate the association between anatomical and clinical results in patients with neovascular age-related macular degeneration (AMD) treated with anti-VEGF in the FRB Registry!.
-
PROMOTOR:
CLINICAL FOUNDATION FOR BIOMEDICAL RESEARCH
-
TIPUS E:
EPA-OD
- Any 2020
- Comprehensive Care Center Dos de Maig Hospital
Phase III, multicenter, randomized, double-masked and parallel-group study to compare the efficacy, safety, tolerability, pharmacokinetics and immunogenicity of SCD411 and Eylea® in subjects with age-related neovascular macular degeneration.
-
PROMOTOR:
SCD (SamChunDang Pharm. Co.,Ltd)
-
TIPUS E:
RD2015
Línies d’actuació- Treatment of retinal diseases with intravitreal medication
- Anti VEGF in diabetic macular edema
- Anti VEGF in central serous chorioretinopathy
- Treatment of Diabetic Retinopathy
- UTI (Unitat de teràpia intravitria )
- New techniques in cataract surgery
- Surgical alternatives to full thickness corneal transplantation
- Microkeratum assisted keratoplasty Anterior and posterior lamellar techniques
Documents
Informació d’interès
Enllaços
